Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07234968 · ClinicalTrials.gov registry record · NA
Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
A NA study of Bladder Cancer and Urothelial Carcinoma, sponsored by Thomas Jefferson University.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 2
- Study locations
NCT07234968 is a NA study of Bladder Cancer and Urothelial Carcinoma that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 70 participants, below the 12,753-participant average among 175 other Bladder Cancer trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT07234968, a NA study of Bladder Cancer and Urothelial Carcinoma, is actively recruiting participants, sponsored by Thomas Jefferson University.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 2
- Study locations
Study Summary
Subjects will be randomized into 2 groups (stent or no stent) prior to radical cystectomy with ileal conduit urinary diversion (RCIC). They will follow the standard of care and be enrolled in the study for 12 months post-op. Risk of post-op complications will be analyzed.
Conditions Studied
Interventions
- PROCEDURE Ureteral Stent Placement
- PROCEDURE No Ureteral Stent
- DIAGNOSTIC_TEST Indocyanine Green with Fluorescence Imaging
Study Locations (2)
Pennsylvania
- Thomas Jefferson University Hospital - Philadelphia
- Jefferson Einstein Philadelphia Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2025-12-23 |
| Est. Completion | 2028-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07234968
The ClinicalTrials.gov registry entry for NCT07234968 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,753-participant average among 175 other Bladder Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Bladder Cancer appearing as the primary indexed condition, and to 3 interventions - of which Ureteral Stent Placement is the first listed.
NCT07234968 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07234968 about?
NCT07234968 is a clinical study titled "Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy". Subjects will be randomized into 2 groups (stent or no stent) prior to radical cystectomy with ileal conduit urinary diversion (RCIC). They will follow the standard of care and be enrolled in the study for 12 months post-op. Risk of post-op complications will be analyzed.
What is the current status of trial NCT07234968?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2025-12-23. Estimated completion is 2028-04-30.
What conditions does trial NCT07234968 study?
This clinical trial studies the following conditions: Bladder Cancer, Urothelial Carcinoma, Muscle-Invasive Bladder Carcinoma, Pelvic Malignancy, Bladder Transitional Cell Carcinoma.
What interventions are being tested in trial NCT07234968?
The interventions under investigation include: Ureteral Stent Placement (PROCEDURE), No Ureteral Stent (PROCEDURE), Indocyanine Green with Fluorescence Imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07234968?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07234968 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bladder Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
RECRUITING · NA
-
CONFIRM: Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
RECRUITING · NA
-
Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.